Corporate News     08-Aug-22
Alembic Pharmaceuticals receives USFDA approval for Adapalene and Benzoyl Peroxide Topical Gel
Alembic Pharmaceuticals (Alembic) today announced that its wholly owned subsidiary, Aleor Dermaceuticals (Aleor) has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Adapalene and Benzoyl Peroxide Topical Gel, 0.3%/2.5%. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Epiduo Forte Topical Gel, 0.3%/2.5%, of Galderma Laboratories, L.P; (Galderma). Adapalene and Benzoy Peroxide Topical Gel, 0.3%/2.5% is indicated for the topical treatment of acne vulgaris in adults and pediatric patients 12 years of age and older.

Adapalene and Benzoyl Peroxide Topical Gel, 0.3%/2.5% has an estimated market size of US$211 million for twelve months ending Mar 2022 according to IQVIA.

Alembic has received a cumulative total of 170 ANDA approvals (146 final approvals and 24 tentative approvals) from USFDA.

Previous News
  Alembic Pharma gets USFDA nod for leukemia drug
 ( Hot Pursuit - 10-Jun-22   11:38 )
  Alembic Pharma’s Gujarat facility gets 4 observations from USFDA
 ( Hot Pursuit - 09-Mar-24   09:04 )
  Alembic Pharma's oncology formulation facility undergoes USFDA audit
 ( Corporate News - 09-Mar-24   12:26 )
  Alembic Pharma gets PAS nod from USFDA for pregabalin capsules
 ( Hot Pursuit - 22-Dec-22   14:57 )
  Alembic Pharma rises after USFDA approves Umbralisib
 ( Hot Pursuit - 09-Feb-21   12:07 )
  Alembic Pharma karkhadi facility gets two USFDA observations
 ( Hot Pursuit - 25-Mar-23   12:35 )
  USFDA inspects Alembic Pharmaceuticals' Karkhadi unit
 ( Corporate News - 24-Mar-23   16:33 )
  Alembic Pharmaceuticals Ltd rises around 1%
 ( Hot Pursuit - 29-Dec-21   13:05 )
  Alembic Pharmaceuticals gets USFDA approval
 ( Corporate News - 10-Jun-22   11:45 )
  Alembic Pharma gets USFDA final nod for Doxycycline Hyclate tablets
 ( Hot Pursuit - 05-Mar-20   11:45 )
  Alembic Pharmaceuticals receives USFDA tentative approval for Vortioxetine Tablets
 ( Corporate News - 07-Jan-22   10:04 )
Other Stories
  Tridhya Tech to convene board meeting
  03-Jul-24   20:06
  Sonu Infratech schedules EGM
  03-Jul-24   19:59
  Sakuma Exports to convene AGM
  03-Jul-24   19:59
  Time Technoplast repays commercial paper
  03-Jul-24   18:31
  Board of Aditya Vision approves stock split and listing of share on NSE
  03-Jul-24   18:24
  Pricol director resigns
  03-Jul-24   18:21
  Board of VMS Industries recommends first interim dividend
  03-Jul-24   17:49
  Lakshmi Machine Works to declare Quarterly Result
  03-Jul-24   17:44
  Modison to convene AGM
  03-Jul-24   17:43
  Sybly Industries to discuss results
  03-Jul-24   17:43
Back Top